CD163 and rheumatoid arthritis: (66) performed macrophage and lymphocyte subset analysis on synovial biopsy samples from 26 patients with spondylitis (SpA) as well as 23 patients with RA, which demonstrated a significant increase in CD163+ SMs that was associated with systemic inflammation and impaired T-cell activation.